THE US Food and Drug
Administration has approved an
infant-specific dose of CREON
(pancrelipase) Delayed-Release
Capsules to treat exocrine
pancreatic insufficiency due to
cystic fibrosis.
The agency has also approved a
new genetic test, Inform Dual ISH,
that will help health care
professionals determine if women
with breast cancer are HER2-
positive and, therefore candidates
for the breast cancer treatment
Herceptin (trastuzumab).
Also on the FDA’s recent approval
list is the first ceramic-on-metal
total artificial hip system for patients
with osteoarthritis, The Pinnacle
Complete Acetabular Hip System.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jun 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jun 11
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.